Materials and methods for cryopreserved bone constructs
View Patent ↗Porous HCG scaffolds are provided in a perfusion bioreactor. Cells are seeded in the HCG scaffolds and cell culture media is perfused through the bioreactor to allow for cell seeding and growth. The cell culture media is removed, the HCG-cell constructs washed, and then preserved in the bioreactor with a perfusion comprising cryopreservation fluid comprising one or more of DMSO, trehalose, glycerol, ethylene glycol, or serum. The HCG-cell constructs (or the perfusion chambers containing them) are then removed from the bioreactor and placed in a cryopreservant media and maintained at about −80° C. The frozen HCG-cell constructs (or the chambers containing them) can then be stored at a suitable cryogenic temperature until needed. When needed, frozen HCG-cell constructs can be removed from cold storage and thawed using suitable means.
1. A method for cryopreservation of HCG-cell construct, said method comprising providing a porous HCG scaffold in a perfusion bioreactor, wherein said perfusion bioreactor comprises perfusion chambers that contain said HCG scaffold; seeding cells in said HCG scaffold and perfusing cell culture media through said bioreactor to produce said HCG-cell construct; removing said cell culture media and optionally washing said HCG-cell construct with a physiologically acceptable wash solution; perfusing said HCG-cell construct with a cryopreservation fluid using a transverse flow of said cryopreservation fluid through said HCG-cell construct in said bioreactor; removing HCG-cell construct from said bioreactor and freezing said HCG-cell construct in a cryopreservation fluid at increasingly colder temperatures over a period of time; and optionally storing said frozen HCG-cell construct at a suitable cryogenic temperature.
2. The method according to claim 1 , wherein said cell is a stem cell.
3. The method according to claim 1 , wherein said cell is from an insect, fish, reptile, amphibian, bird, or mammal.
4. The method according to claim 1 , wherein said cell is a human mesenchymal stem cell.
5. The method according to claim 1 , wherein said physiologically acceptable wash buffer is PBS.
6. The method according to claim 1 , wherein said cryopreservation fluid comprises DMSO and trehalose.
7. The method according to claim 1 , wherein said freezing step comprises exposing said HCG-cell construct to about 4° C. for about 1 hour, then about −20° C. for about 2 hours, and then about −80° C. for several hours.
8. The method according to claim 1 , wherein said porous HCG scaffold is in the three-dimensional shape of a bone or a portion of said bone.
9. The method according to claim 1 , wherein said bone is a femur bone, a tibia, a fibula, a humerus, a radius, an ulna, a patella, a cranial bone, a maxillofacial bone, a spinal bone, a scapula, a clavicle, a carpal or metacarpal bone, a tarsal or metatarsal bone, or a pelvic bone, or any other bone in an animal body.
10. The method according to claim 1 , wherein said cryopreserved HCG-cell construct is stored in liquid nitrogen.
11. A cryopreserved cell from an HCG-cell construct prepared according to the method of claim 1 .
12. A cryopreserved HCG-cell construct prepared according to the method of claim 1 .
13. A kit comprising a cryopreserved cell or an HCG-cell construct prepared according to the method of claim 1 and one or more containers.
14. The kit according to claim 13 , wherein said kit further comprises instructions or labeling for the use of said kit.
15. The cell according to claim 11 , wherein said cell is a human mesenchymal stem cell.
16. The HCG-cell construct according to claim 12 , wherein said cell is a human mesenchymal stem cell.
17. The method according to claim 1 , wherein said cryopreservation fluid comprises one or more of DMSO, trehalose, glycerol, ethylene glycol, or serum.